Startups
New drug application (NDA) IB1001 developer for the treatment of Niemann-pick disease type C (NPC).
Summary
17
Industry
Total funding Amount
$51M
Fundraising History
-
Mar 23 '24 Series B$40M
-
Aug 17 '18 Series A$10M